Core Laboratories (CLB) Proxy filing summary

Executive summary

• The annual meeting is scheduled for May 12, 2026, with shareholders voting on director elections, auditor ratification, and executive compensation approval.

• Shareholders of record as of March 18, 2026, are entitled to vote, with 46,048,268 shares outstanding.

• Proxy materials are available online, and shareholders can vote by mail, phone, or internet.

Voting matters and shareholder proposals

• Proposals include re-election of two Class I Directors, ratification of KPMG as auditor for 2026, and an advisory vote on executive compensation.

• Shareholder proposals for the 2027 meeting must be submitted by December 1, 2026.

Board of directors and corporate governance

• The board consists of seven directors divided into three classes, with a mix of industry, financial, and governance expertise.

• Six of seven directors are independent under NYSE and SEC standards.

• The board has Audit, Compensation, and Nominating Committees, all comprised of independent directors.

• Mandatory resignation and retirement policies are in place for directors.